Regulation of gastrointestinal neuromuscular function by NIBP/NFkB signaling

点击翻译按钮获取中文摘要

DESCRIPTION (provided by applicant): The enteric nervous system (ENS) plays an important role in the regulation of gastrointestinal (GI) functions. Morphological changes and functional abnormalities in adult ENS have been associated with inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), gastroparesis and chronic constipation/diarrhea. The immune and inflammatory responses, in addition to genetic and environmental factors, play critical roles in the pathogenesis of these GI diseases. Most of the immune responses are mediated by the signaling of nuclear factor kB (NFkB). During the current funding period, we demonstrated that NFkB signaling in smooth muscle mediates inflammation-induced inhibition of colonic smooth muscle contraction. There is a fundamental gap in understanding how NFkB signaling from the ENS influences GI diseases. The long-term goal is to understand the role of NFkB signaling in the regulation of GI functions in health and during inflammation. The objective of this renewal is to elucidate the importance of enteric neuron- and astroglia-specific NFkB signaling in regulating GI neuromuscular function. The central hypothesis is that enteric neuronal NFkB signaling is required for the maintenance of GI functional integrity while enteric glial NFkB signaling regulates neuronal functions under normal conditions but mediates inflammatory responses under inflamed conditions. This hypothesis will be tested by parallel studies on the effects of enteric neuronal and astroglial NFkB signaling manipulation on GI contractility under normal and inflamed conditions using 4 lines of conditional gene knockout or knockin mice. In aim 1, we will use enteric neuron-specific conditional knockout of NIBP or knockin of IKK2CA (Constitutively Active form) mice to inactivate or overactivate enteric neuronal NFkB signaling, respectively. In aim 2, we will use GFAP-dnIkB? or GFAP-IKK2CA transgenic mice to inactivate or overactivate enteric astroglial NFkB signaling, respectively. In both aims, we will determine changes in (a) chemical coding and morphology of enteric neurons and glial cells, (b) nerve-stimulated and agonist-induced GI contraction/relaxation, and (c) expression patterns of contractile proteins and inflammatory mediators in smooth muscles. Completion of these studies will demonstrate for the first time the importance of neuronal NFkB signaling in the maintenance of ENS functional integrity and astroglial NFkB signaling in facilitating gliotic and inflammatory responses that contribute to the development and progression of chronic inflammation. This proposal is innovative both in concept implicating neuronal NIBP in the regulation of ENS functions and astroglial NFkB in the regulation of inflammation, and in the use of novel neuron- and astroglia-specific transgenic mice. Our studies will highlight the importance of ENS NFkB signaling and provide a novel mechanism for the pathogenesis of neurogastrointestinal disorders.